Literature DB >> 34248461

From BRCA1 to Polygenic Risk Scores: Mutation-Associated Risks in Breast Cancer-Related Genes.

Emma R Woodward1,2, Elke M van Veen1,2, D Gareth Evans1,2,3,4.   

Abstract

BACKGROUND: There has been huge progress over the last 30 years in identifying the familial component of breast cancer.
SUMMARY: Currently around 20% is explained by the high-risk genes BRCA1 and BRCA2, a further 2% by other high-penetrance genes, and around 5% by the moderate risk genes ATM and CHEK2. In contrast, the more than 300 low-penetrance single-nucleotide polymorphisms (SNP) now account for around 28% and they are predicted to account for most of the remaining 45% yet to be found. Even for high-risk genes which confer a 40-90% risk of breast cancer, these SNP can substantially affect the level of breast cancer risk. Indeed, the strength of family history and hormonal and reproductive factors is very important in assessing risk even for a BRCA carrier. The risks of contralateral breast cancer are also affected by SNP as well as by the presence of high or moderate risk genes. Genetic testing using gene panels is now commonplace. KEY-MESSAGES: There is a need for a more parsimonious approach to panels only testing those genes with a definite 2-fold increased risk and only testing those genes with challenging management implications, such as CDH1 and TP53, when there is strong clinical indication to do so. Testing of SNP alongside genes is likely to provide a more accurate risk assessment.
Copyright © 2021 by S. Karger AG, Basel.

Entities:  

Keywords:  BRCA1; BRCA2; Breast cancer; High-risk genes; TP53

Year:  2021        PMID: 34248461      PMCID: PMC8248775          DOI: 10.1159/000515319

Source DB:  PubMed          Journal:  Breast Care (Basel)        ISSN: 1661-3791            Impact factor:   2.860


  107 in total

1.  BRCA2 mutations in a population-based series of patients with ocular melanoma.

Authors:  Rodney J Scott; Claire M Vajdic; Bruce K Armstrong; Christopher J Ainsworth; Cliff J Meldrum; Joanne F Aitken; Anne Kricker
Journal:  Int J Cancer       Date:  2002-11-10       Impact factor: 7.396

2.  Risk of breast cancer in male BRCA2 carriers.

Authors:  D G R Evans; I Susnerwala; J Dawson; E Woodward; E R Maher; F Lalloo
Journal:  J Med Genet       Date:  2010-06-28       Impact factor: 6.318

3.  Long-term outcomes of breast cancer in women aged 30 years or younger, based on family history, pathology and BRCA1/BRCA2/TP53 status.

Authors:  D G R Evans; A Moran; R Hartley; J Dawson; B Bulman; F Knox; A Howell; F Lalloo
Journal:  Br J Cancer       Date:  2010-03-16       Impact factor: 7.640

4.  Probability of BRCA1/2 mutation varies with ovarian histology: results from screening 442 ovarian cancer families.

Authors:  D G R Evans; K Young; M Bulman; A Shenton; A Wallace; F Lalloo
Journal:  Clin Genet       Date:  2008-02-26       Impact factor: 4.438

5.  A common coding variant in CASP8 is associated with breast cancer risk.

Authors:  Angela Cox; Alison M Dunning; Montserrat Garcia-Closas; Sabapathy Balasubramanian; Malcolm W R Reed; Karen A Pooley; Serena Scollen; Caroline Baynes; Bruce A J Ponder; Stephen Chanock; Jolanta Lissowska; Louise Brinton; Beata Peplonska; Melissa C Southey; John L Hopper; Margaret R E McCredie; Graham G Giles; Olivia Fletcher; Nichola Johnson; Isabel dos Santos Silva; Lorna Gibson; Stig E Bojesen; Børge G Nordestgaard; Christen K Axelsson; Diana Torres; Ute Hamann; Christina Justenhoven; Hiltrud Brauch; Jenny Chang-Claude; Silke Kropp; Angela Risch; Shan Wang-Gohrke; Peter Schürmann; Natalia Bogdanova; Thilo Dörk; Rainer Fagerholm; Kirsimari Aaltonen; Carl Blomqvist; Heli Nevanlinna; Sheila Seal; Anthony Renwick; Michael R Stratton; Nazneen Rahman; Suleeporn Sangrajrang; David Hughes; Fabrice Odefrey; Paul Brennan; Amanda B Spurdle; Georgia Chenevix-Trench; Jonathan Beesley; Arto Mannermaa; Jaana Hartikainen; Vesa Kataja; Veli-Matti Kosma; Fergus J Couch; Janet E Olson; Ellen L Goode; Annegien Broeks; Marjanka K Schmidt; Frans B L Hogervorst; Laura J Van't Veer; Daehee Kang; Keun-Young Yoo; Dong-Young Noh; Sei-Hyun Ahn; Sara Wedrén; Per Hall; Yen-Ling Low; Jianjun Liu; Roger L Milne; Gloria Ribas; Anna Gonzalez-Neira; Javier Benitez; Alice J Sigurdson; Denise L Stredrick; Bruce H Alexander; Jeffery P Struewing; Paul D P Pharoah; Douglas F Easton
Journal:  Nat Genet       Date:  2007-02-11       Impact factor: 38.330

6.  Distribution of breast cancer risk from SNPs and classical risk factors in women of routine screening age in the UK.

Authors:  A R Brentnall; D G Evans; J Cuzick
Journal:  Br J Cancer       Date:  2014-01-21       Impact factor: 7.640

7.  Prediction of Breast and Prostate Cancer Risks in Male BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk Scores.

Authors:  Julie Lecarpentier; Valentina Silvestri; Karoline B Kuchenbaecker; Daniel Barrowdale; Joe Dennis; Lesley McGuffog; Penny Soucy; Goska Leslie; Piera Rizzolo; Anna Sara Navazio; Virginia Valentini; Veronica Zelli; Andrew Lee; Ali Amin Al Olama; Jonathan P Tyrer; Melissa Southey; Esther M John; Thomas A Conner; David E Goldgar; Saundra S Buys; Ramunas Janavicius; Linda Steele; Yuan Chun Ding; Susan L Neuhausen; Thomas V O Hansen; Ana Osorio; Jeffrey N Weitzel; Angela Toss; Veronica Medici; Laura Cortesi; Ines Zanna; Domenico Palli; Paolo Radice; Siranoush Manoukian; Bernard Peissel; Jacopo Azzollini; Alessandra Viel; Giulia Cini; Giuseppe Damante; Stefania Tommasi; Paolo Peterlongo; Florentia Fostira; Ute Hamann; D Gareth Evans; Alex Henderson; Carole Brewer; Diana Eccles; Jackie Cook; Kai-Ren Ong; Lisa Walker; Lucy E Side; Mary E Porteous; Rosemarie Davidson; Shirley Hodgson; Debra Frost; Julian Adlard; Louise Izatt; Ros Eeles; Steve Ellis; Marc Tischkowitz; Andrew K Godwin; Alfons Meindl; Andrea Gehrig; Bernd Dworniczak; Christian Sutter; Christoph Engel; Dieter Niederacher; Doris Steinemann; Eric Hahnen; Jan Hauke; Kerstin Rhiem; Karin Kast; Norbert Arnold; Nina Ditsch; Shan Wang-Gohrke; Barbara Wappenschmidt; Dorothea Wand; Christine Lasset; Dominique Stoppa-Lyonnet; Muriel Belotti; Francesca Damiola; Laure Barjhoux; Sylvie Mazoyer; Mattias Van Heetvelde; Bruce Poppe; Kim De Leeneer; Kathleen B M Claes; Miguel de la Hoya; Vanesa Garcia-Barberan; Trinidad Caldes; Pedro Perez Segura; Johanna I Kiiski; Kristiina Aittomäki; Sofia Khan; Heli Nevanlinna; Christi J van Asperen; Tibor Vaszko; Miklos Kasler; Edith Olah; Judith Balmaña; Sara Gutiérrez-Enríquez; Orland Diez; Alex Teulé; Angel Izquierdo; Esther Darder; Joan Brunet; Jesús Del Valle; Lidia Feliubadalo; Miquel Angel Pujana; Conxi Lazaro; Adalgeir Arason; Bjarni A Agnarsson; Oskar Th Johannsson; Rosa B Barkardottir; Elisa Alducci; Silvia Tognazzo; Marco Montagna; Manuel R Teixeira; Pedro Pinto; Amanda B Spurdle; Helene Holland; Jong Won Lee; Min Hyuk Lee; Jihyoun Lee; Sung-Won Kim; Eunyoung Kang; Zisun Kim; Priyanka Sharma; Timothy R Rebbeck; Joseph Vijai; Mark Robson; Anne Lincoln; Jacob Musinsky; Pragna Gaddam; Yen Y Tan; Andreas Berger; Christian F Singer; Jennifer T Loud; Mark H Greene; Anna Marie Mulligan; Gord Glendon; Irene L Andrulis; Amanda Ewart Toland; Leigha Senter; Anders Bojesen; Henriette Roed Nielsen; Anne-Bine Skytte; Lone Sunde; Uffe Birk Jensen; Inge Sokilde Pedersen; Lotte Krogh; Torben A Kruse; Maria A Caligo; Sook-Yee Yoon; Soo-Hwang Teo; Anna von Wachenfeldt; Dezheng Huo; Sarah M Nielsen; Olufunmilayo I Olopade; Katherine L Nathanson; Susan M Domchek; Christa Lorenchick; Rachel C Jankowitz; Ian Campbell; Paul James; Gillian Mitchell; Nick Orr; Sue Kyung Park; Mads Thomassen; Kenneth Offit; Fergus J Couch; Jacques Simard; Douglas F Easton; Georgia Chenevix-Trench; Rita K Schmutzler; Antonis C Antoniou; Laura Ottini
Journal:  J Clin Oncol       Date:  2017-04-27       Impact factor: 44.544

8.  Use of Single-Nucleotide Polymorphisms and Mammographic Density Plus Classic Risk Factors for Breast Cancer Risk Prediction.

Authors:  Elke M van Veen; Adam R Brentnall; Helen Byers; Elaine F Harkness; Susan M Astley; Sarah Sampson; Anthony Howell; William G Newman; Jack Cuzick; D Gareth R Evans
Journal:  JAMA Oncol       Date:  2018-04-01       Impact factor: 31.777

9.  Genome-wide association studies identify four ER negative-specific breast cancer risk loci.

Authors:  Montserrat Garcia-Closas; Fergus J Couch; Sara Lindstrom; Kyriaki Michailidou; Marjanka K Schmidt; Mark N Brook; Nick Orr; Suhn Kyong Rhie; Elio Riboli; Heather S Feigelson; Loic Le Marchand; Julie E Buring; Diana Eccles; Penelope Miron; Peter A Fasching; Hiltrud Brauch; Jenny Chang-Claude; Jane Carpenter; Andrew K Godwin; Heli Nevanlinna; Graham G Giles; Angela Cox; John L Hopper; Manjeet K Bolla; Qin Wang; Joe Dennis; Ed Dicks; Will J Howat; Nils Schoof; Stig E Bojesen; Diether Lambrechts; Annegien Broeks; Irene L Andrulis; Pascal Guénel; Barbara Burwinkel; Elinor J Sawyer; Antoinette Hollestelle; Olivia Fletcher; Robert Winqvist; Hermann Brenner; Arto Mannermaa; Ute Hamann; Alfons Meindl; Annika Lindblom; Wei Zheng; Peter Devillee; Mark S Goldberg; Jan Lubinski; Vessela Kristensen; Anthony Swerdlow; Hoda Anton-Culver; Thilo Dörk; Kenneth Muir; Keitaro Matsuo; Anna H Wu; Paolo Radice; Soo Hwang Teo; Xiao-Ou Shu; William Blot; Daehee Kang; Mikael Hartman; Suleeporn Sangrajrang; Chen-Yang Shen; Melissa C Southey; Daniel J Park; Fleur Hammet; Jennifer Stone; Laura J Van't Veer; Emiel J Rutgers; Artitaya Lophatananon; Sarah Stewart-Brown; Pornthep Siriwanarangsan; Julian Peto; Michael G Schrauder; Arif B Ekici; Matthias W Beckmann; Isabel Dos Santos Silva; Nichola Johnson; Helen Warren; Ian Tomlinson; Michael J Kerin; Nicola Miller; Federick Marme; Andreas Schneeweiss; Christof Sohn; Therese Truong; Pierre Laurent-Puig; Pierre Kerbrat; Børge G Nordestgaard; Sune F Nielsen; Henrik Flyger; Roger L Milne; Jose Ignacio Arias Perez; Primitiva Menéndez; Heiko Müller; Volker Arndt; Christa Stegmaier; Peter Lichtner; Magdalena Lochmann; Christina Justenhoven; Yon-Dschun Ko; Taru A Muranen; Kristiina Aittomäki; Carl Blomqvist; Dario Greco; Tuomas Heikkinen; Hidemi Ito; Hiroji Iwata; Yasushi Yatabe; Natalia N Antonenkova; Sara Margolin; Vesa Kataja; Veli-Matti Kosma; Jaana M Hartikainen; Rosemary Balleine; Chiu-Chen Tseng; David Van Den Berg; Daniel O Stram; Patrick Neven; Anne-Sophie Dieudonné; Karin Leunen; Anja Rudolph; Stefan Nickels; Dieter Flesch-Janys; Paolo Peterlongo; Bernard Peissel; Loris Bernard; Janet E Olson; Xianshu Wang; Kristen Stevens; Gianluca Severi; Laura Baglietto; Catriona McLean; Gerhard A Coetzee; Ye Feng; Brian E Henderson; Fredrick Schumacher; Natalia V Bogdanova; France Labrèche; Martine Dumont; Cheng Har Yip; Nur Aishah Mohd Taib; Ching-Yu Cheng; Martha Shrubsole; Jirong Long; Katri Pylkäs; Arja Jukkola-Vuorinen; Saila Kauppila; Julia A Knight; Gord Glendon; Anna Marie Mulligan; Robertus A E M Tollenaar; Caroline M Seynaeve; Mieke Kriege; Maartje J Hooning; Ans M W van den Ouweland; Carolien H M van Deurzen; Wei Lu; Yu-Tang Gao; Hui Cai; Sabapathy P Balasubramanian; Simon S Cross; Malcolm W R Reed; Lisa Signorello; Qiuyin Cai; Mitul Shah; Hui Miao; Ching Wan Chan; Kee Seng Chia; Anna Jakubowska; Katarzyna Jaworska; Katarzyna Durda; Chia-Ni Hsiung; Pei-Ei Wu; Jyh-Cherng Yu; Alan Ashworth; Michael Jones; Daniel C Tessier; Anna González-Neira; Guillermo Pita; M Rosario Alonso; Daniel Vincent; Francois Bacot; Christine B Ambrosone; Elisa V Bandera; Esther M John; Gary K Chen; Jennifer J Hu; Jorge L Rodriguez-Gil; Leslie Bernstein; Michael F Press; Regina G Ziegler; Robert M Millikan; Sandra L Deming-Halverson; Sarah Nyante; Sue A Ingles; Quinten Waisfisz; Helen Tsimiklis; Enes Makalic; Daniel Schmidt; Minh Bui; Lorna Gibson; Bertram Müller-Myhsok; Rita K Schmutzler; Rebecca Hein; Norbert Dahmen; Lars Beckmann; Kirsimari Aaltonen; Kamila Czene; Astrid Irwanto; Jianjun Liu; Clare Turnbull; Nazneen Rahman; Hanne Meijers-Heijboer; Andre G Uitterlinden; Fernando Rivadeneira; Curtis Olswold; Susan Slager; Robert Pilarski; Foluso Ademuyiwa; Irene Konstantopoulou; Nicholas G Martin; Grant W Montgomery; Dennis J Slamon; Claudia Rauh; Michael P Lux; Sebastian M Jud; Thomas Bruning; Joellen Weaver; Priyanka Sharma; Harsh Pathak; Will Tapper; Sue Gerty; Lorraine Durcan; Dimitrios Trichopoulos; Rosario Tumino; Petra H Peeters; Rudolf Kaaks; Daniele Campa; Federico Canzian; Elisabete Weiderpass; Mattias Johansson; Kay-Tee Khaw; Ruth Travis; Françoise Clavel-Chapelon; Laurence N Kolonel; Constance Chen; Andy Beck; Susan E Hankinson; Christine D Berg; Robert N Hoover; Jolanta Lissowska; Jonine D Figueroa; Daniel I Chasman; Mia M Gaudet; W Ryan Diver; Walter C Willett; David J Hunter; Jacques Simard; Javier Benitez; Alison M Dunning; Mark E Sherman; Georgia Chenevix-Trench; Stephen J Chanock; Per Hall; Paul D P Pharoah; Celine Vachon; Douglas F Easton; Christopher A Haiman; Peter Kraft
Journal:  Nat Genet       Date:  2013-04       Impact factor: 38.330

10.  European polygenic risk score for prediction of breast cancer shows similar performance in Asian women.

Authors:  Weang-Kee Ho; Min-Min Tan; Nasim Mavaddat; Mei-Chee Tai; Shivaani Mariapun; Jingmei Li; Peh-Joo Ho; Joe Dennis; Jonathan P Tyrer; Manjeet K Bolla; Kyriaki Michailidou; Qin Wang; Daehee Kang; Ji-Yeob Choi; Suniza Jamaris; Xiao-Ou Shu; Sook-Yee Yoon; Sue K Park; Sung-Won Kim; Chen-Yang Shen; Jyh-Cherng Yu; Ern Yu Tan; Patrick Mun Yew Chan; Kenneth Muir; Artitaya Lophatananon; Anna H Wu; Daniel O Stram; Keitaro Matsuo; Hidemi Ito; Ching Wan Chan; Joanne Ngeow; Wei Sean Yong; Swee Ho Lim; Geok Hoon Lim; Ava Kwong; Tsun L Chan; Su Ming Tan; Jaime Seah; Esther M John; Allison W Kurian; Woon-Puay Koh; Chiea Chuen Khor; Motoki Iwasaki; Taiki Yamaji; Kiak Mien Veronique Tan; Kiat Tee Benita Tan; John J Spinelli; Kristan J Aronson; Siti Norhidayu Hasan; Kartini Rahmat; Anushya Vijayananthan; Xueling Sim; Paul D P Pharoah; Wei Zheng; Alison M Dunning; Jacques Simard; Rob Martinus van Dam; Cheng-Har Yip; Nur Aishah Mohd Taib; Mikael Hartman; Douglas F Easton; Soo-Hwang Teo; Antonis C Antoniou
Journal:  Nat Commun       Date:  2020-07-31       Impact factor: 14.919

View more
  3 in total

1.  Relationship between Telomere Length, TERT Genetic Variability and TERT, TP53, SP1, MYC Gene Co-Expression in the Clinicopathological Profile of Breast Cancer.

Authors:  Marta Dratwa; Barbara Wysoczanska; Wioletta Brankiewicz; Martyna Stachowicz-Suhs; Joanna Wietrzyk; Rafał Matkowski; Marcin Ekiert; Jolanta Szelachowska; Adam Maciejczyk; Mariusz Szajewski; Maciej Baginski; Katarzyna Bogunia-Kubik
Journal:  Int J Mol Sci       Date:  2022-05-05       Impact factor: 6.208

Review 2.  Fibroblast growth factor receptor signalling dysregulation and targeting in breast cancer.

Authors:  Chiara Francavilla; Ciara S O'Brien
Journal:  Open Biol       Date:  2022-02-23       Impact factor: 6.411

Review 3.  Impact of DNA damage response defects in cancer cells on response to immunotherapy and radiotherapy.

Authors:  Daniel Czajkowski; Radosław Szmyd; Harriet E Gee
Journal:  J Med Imaging Radiat Oncol       Date:  2022-04-23       Impact factor: 1.667

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.